Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [1985]
News [3223]
Articles [134]
Editorials [3]
Conferences [121]
elearning [18]
KRd vs VRd for initial therapy of newly diagnosed multiple myeloma
Dr Shaji Kumar - Mayo Clinic, Rochester, USA
KRd vs VRd for initial therapy of newly diagnosed multiple myeloma ( Dr Shaji Kumar - Mayo Clinic, Rochester, USA )
1 Jun 2020
Teclistamab for patients with heavily pretreated relapsed or refractory...
Dr Saad Usmani - Levine Cancer Institute, Charlotte, USA
Teclistamab for patients with heavily pretreated relapsed or refractory multiple myeloma ( Dr Saad Usmani - Levine Cancer Institute, Charlotte, USA )
1 Jun 2020
Denosumab in multiple myeloma patients with renal insufficiency
Dr Elizabeth O'Donnell - Massachusetts General Hospital, Boston, USA
Denosumab in multiple myeloma patients with renal insufficiency ( Dr Elizabeth O'Donnell - Massachusetts General Hospital, Boston, USA )
30 May 2020
CARTITUDE-1: JNJ-4528, a B-cell maturation antigen (BCMA)-directed CAR-T-cell...
Dr Jesus Berdeja - Sarah Cannon Research Institute, Nashville, USA
CARTITUDE-1: JNJ-4528, a B-cell maturation antigen (BCMA)-directed CAR-T-cell therapy for r/r multiple myeloma ( Dr Jesus Berdeja - Sarah Cannon Research Institute, Nashville, USA )
29 May 2020
Managing Hodgkin lymphoma during the COVID-19 outbreak
Dr Anna Sureda - Hospitalet de Llobregat, Barcelona, Spain
Managing Hodgkin lymphoma during the COVID-19 outbreak ( Dr Anna Sureda - Hospitalet de Llobregat, Barcelona, Spain )
20 Apr 2020
Managing multiple myeloma during the COVID-19 outbreak
Dr Robert Rifkin - Rocky Mountain Cancer Centers, Denver, USA
Managing multiple myeloma during the COVID-19 outbreak ( Dr Robert Rifkin - Rocky Mountain Cancer Centers, Denver, USA )
17 Apr 2020
Managing Hodgkin lymphoma in a COVID-19 world
Prof Andreas Engert - University Hospital of Cologne, Cologne, Germany
Managing Hodgkin lymphoma in a COVID-19 world ( Prof Andreas Engert - University Hospital of Cologne, Cologne, Germany )
17 Apr 2020
Immune checkpoint based approaches in AML and MDS
Dr Naval Daver - University of Texas MD Anderson Cancer Center, Houston, USA
Immune checkpoint based approaches in AML and MDS ( Dr Naval Daver - University of Texas MD Anderson Cancer Center, Houston, USA )
8 Apr 2020
CARTs for the treatment of T-cell malignancies
Dr John DiPersio - Siteman Cancer Center, St. Louis, USA
CARTs for the treatment of T-cell malignancies ( Dr John DiPersio - Siteman Cancer Center, St. Louis, USA )
1 Apr 2020
Treating haematological cancers in Romania
Dr Ciprian Tomuleasa - Ion Chiricuta Clinical Research Center, Cluj Napoca...
Treating haematological cancers in Romania ( Dr Ciprian Tomuleasa - Ion Chiricuta Clinical Research Center, Cluj Napoca, Romania )
10 Mar 2020
The landscape of haematological cancers in India
Dr Hemant Malhotra - Mahatma Gandhi Medical College Hospital, Jaipur, India
The landscape of haematological cancers in India ( Dr Hemant Malhotra - Mahatma Gandhi Medical College Hospital, Jaipur, India )
10 Mar 2020
Haematological malignancies: Latest advances from ASH 2019
Dr Eloísa Riva - Hospital de Clínicas, Montevideo, Uruguay
Haematological malignancies: Latest advances from ASH 2019 ( Dr Eloísa Riva - Hospital de Clínicas, Montevideo, Uruguay )
10 Mar 2020

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation